| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.004 |